The director of the National Institutes of Health said he's concerned that vaccine 'skepticism' could hinder the effort to immunize the country against Covid-19
The director of the National Institutes of Health said Thursday he's concerned that vaccine"skepticism" could hinder the effort to immunize the country against Covid-19.
"I'm a bit concerned to see there's a fair amount of skepticism in the American public about whether or not they would take such a vaccine," Dr. Francis Collins told CNN in an interview."We won't get past Covid-19 unless we have a substantial majority of our public ultimately rendered immune." Some vaccine experts are concerned that President Trump's chosen moniker for the vaccine development campaign --"Operation Warp Speed" -- isn't helping.
Collins said the Phase 3 trials will reveal whether one or two injections will be necessary. "There is certainly a chance that one or more of these vaccines might turn out to require two shots in order to get full immune response. That's one of the reasons to do the experiments and the research trials to find that out," he said."If what it takes to provide full protection for any of these is two doses, we want to know that.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
NIH Director Hopes For At Least 1 Safe And Effective Vaccine By Year's EndDr. Francis Collins says some candidates for a coronavirus vaccine will be ready to start large-scale human trials as early as next month. Scaling up production may start before tests are complete.
続きを読む »
Trump prioritizes 5 coronavirus vaccine programs: Moderna, J&J, Merck - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
The Latest Developments In Global Coronavirus Vaccine CompetitionNPR's Sarah McCammon talks with Dr. Francis Collins, director of the National Institutes of Health and a White House coronavirus task force member, about the latest in the coronavirus research.
続きを読む »
Tyson the alpaca takes heavyweight role in search for coronavirus vaccineScientists in Sweden are hoping an alpaca named Tyson can help deliver a knockout blow in the fight to develop a treatment or vaccine against the novel coronavirus that has killed nearly 400,000 people worldwide.
続きを読む »
A coronavirus vaccine could require you to get two shots. Here's why.There's a high likelihood a coronavirus vaccine will need two shots a month or so apart, with the possibility of a booster several years later.
続きを読む »
Brazil health regulator approves clinical trials of Oxford COVID-19 vaccineBrazil's health regulator Anvisa has approved human clinical trials for a potential coronavirus vaccine developed by scientists at Oxford University and supported by AstraZeneca Plc, it said on Wednesday.
続きを読む »